The Royal Melbourne Hospital

Melbourne, Victoria 3050

2 studies enrolling now · 8 studies all time

What they study most

Antifungal Agents, Breast Cancer, Breast Cancer Female, Drug Resistant Epilepsy, Epilepsy, Kidney Transplant Rejection, Partial Epilepsy, Seizures, Surgical Site Infection, Type 2 Diabetes

Studies at this site

• Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study — Recruiting now
• Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE) — Recruiting now
• A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures — Completed
• Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System. — Completed
• An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients — Completed
• A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics — Completed
• Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern — Completed
• Screening Anti-Fungal Exposure in Intensive Care Units — Status unconfirmed